The Motley Fool

ISA investors! Could this megatrend help you get rich and retire early?

Image source: Getty Images.

Looking to get seriously rich in this new decade? Of course you are. The booming pet care market is a hot trend you should definitely look to capitalise on this decade. It’s what I’ve done in recent days. And in particular, the veterinary medicine segment is one to watch in the years ahead.

According to a Fortune Business Insight report, the worldwide vet drugs market will surge to $27.6bn by 2025. This would represent an almost-$10bn jump in a mere eight years. It also suggests a healthy compound annual growth rate of 5.6%. And it’s a market which Animalcare Group (LSE: ANCR) is well placed to capitalise on.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Moving back into growth?

This AIM-quoted business develops, supplies and markets various products and services to vets across the world. Trading here hasn’t been that strong of late, sure. Sales fell 1.5% in 2019, it said last week, because of supply-side issues and falling use of antibiotics for livestock.

However, the launch of new products recently should help it recover. Animalcare cut the ribbon on four new drugs last year alone, and hopes to receive regulatory sign off on another in 2020. It also plans to submit a pain-relieving treatment for approval this quarter.

City analysts expect Animalcare to bounce back into the black with a 2% earnings rise this year. And predictions of improving momentum lead to expectations of a 6% bottom-line increase in 2021.

Balance sheet betterment

The huge improvement Animalcare is making to its balance sheet bodes well for the future too. Underlying cash conversion rose to 92.3% in the first half of 2019, up from 80% the year before. And the business confirmed last month it expects to report a “significant improvement” in the rate when full-year results come out on 31 March.

Thanks to this exceptional cash conversion net debt is toppling too. This fell by around a third year-on-year in 2019 to £15.9m, Animalcare has said. This further bolsters the company’s financial firepower when it comes to investing in R&D to drive future growth.

Animal magic

Now Animalcare isn’t exactly cheap. Not on paper at least. At current prices it carries a forward P/E ratio of 16.2 times. Such a reading may put off many stock pickers given the supply-related issues it’s had of late too.

I consider this reading to be quite undemanding though, when you consider the company’s immense structural opportunities in the next decade and beyond. Besides, those supply problems it experienced with third-party manufacturers last year are a thing of the past.

In fact, the petcare specialist still trades at a considerable discount to some of its industry rivals on the back of these previous troubles. Fellow drugmaker Dechra Pharmaceuticals for instance trades on a forward P/E multiple of above 30 times. Those looking for solid growth prospects at great value need to give Animalcare some close attention today.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.